Scientific Online Resource System

Varna Medical Forum

Study of the use of valeriana-containing products in Bulgaria for the period 2014-2016

Iva Anestieva, Stefka Valcheva-Kuzmanova

Abstract

Valerian (Valeriana officinalis) is a very popular herb which is used mainly to treat insomnia and anxiety. The purpose of this study was to explore the available on the market in Bulgaria pharmaceuticals and food supplements containing valerian, and to analyze the use of such products. The use of valeriancontaining products was studied by collecting sales data from 19 pharmacies in Varna for the period 2014-2016. The results showed a great variety of monoproducts and combined products containing valerian on the pharmaceutical market in Bulgaria. The pharmaceuticals are two, and the food supplements are above 35. In the studied period, there was an increase in the sales of valerian-containing products which could be explained by the increasing stress in everyday life. The price of the products during the study period remained relatively constant. Predominant was the use of combined products that


Keywords

Валериана; лекарствени продукти; хранителни добавки; употреба; България; Valerian, pharmaceuticals, food supplements, use, Bulgaria

Full Text


References

Abourashed EA, Koetter U, Brattström A. In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine. 2004;11(7-8):633-638.

Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: A randomized placebo-controlled pilot study. Phytother Res. 2002;16:650-654.

Circosta C, De Pasquale R, Samperi S, Pino A, Occhiuto F. Biological and analytical characterization of two extracts from Valeriana officinalis. J Ethnopharmacol. 2007;112:361-637.

Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 2005;138(2):191-197.

Hadley S, Petry JJ. Valerian. Am Fam Physician.2003;67:1755-1758.

Hendriks H, Bos R, Allersma DP, Malingré TM, Koster AS. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Med. 1981;42:62-68.

Hoffmann D. The Complete Illustrated Holistic Herbal: A Safe and Practical Guide to Making and Using Herbal Remedies. Shaftesbury, Dorset: Element Books; 1996. p. 256.

Klich R. Behavior disorders in childhood and their therapy. Med Welt. 1975;26:1251-1254.

Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine. 2010;17(8-9):674-678.

Ortiz JG, Nieves-Natal J, Chavez P. Effects of Valeriana officinalis extracts on [3H] flunitrazepam binding, synaptosomal [3H] GABA uptake, and hippocampal [3H] GABA release. Neurochem Res. 1999;24:1373-1378.

Oshima Y, Matsuoka S, Ohizumi Y. Antidepressant principles of Valeriana fauriei roots. Chem Pharm Bull (Tokyo). 1995;43:169-170.

Peirce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: William Morrow and Company, Inc.; 1999.

Wagner H, Jurcic K, Schaette R. Comparative studies on the sedative action of Valeriana extracts, valepotriates and their degradation products (author’s transl) Planta Med. 1980;39:358-365.

Е аптека Фрамар. Available from: http://www.framar.bg




DOI: http://dx.doi.org/10.14748/vmf.v6i1.2192

Refbacks

Font Size


|